Hardy Reed’s Novo Nordisk NVO Stock Holding History

Hardy Reed’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$218K	Buy	+4,546	New	+$195K	0.01%	241
2026 Q1	–	Sell	-7,177	Closed	-$365K	–	253
2025 Q4	$365K	Buy	7,177 +90	+1%	+$4.6K	0.03%	176
2025 Q3	$393K	Sell	7,087 -1,445	-17%	-$84.6K	0.03%	165
2025 Q2	$589K	Buy	8,532 +238	+3%	+$16.2K	0.05%	126
2025 Q1	$576K	Sell	8,294 -56	-0.7%	-$4.63K	0.05%	121
2024 Q4	$718K	Sell	8,350 -1	-0%	-$108	0.06%	108
2024 Q3	$994K	Buy	8,351 +2	+0%	+$267	0.09%	95
2024 Q2	$1.19M	Buy	+8,349	New	+$1.11M	0.12%	86

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hardy Reed's NVO Position: Q2 2026 in Review

Hardy Reed opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,546 shares worth $218K. The stake represents 0.01% of the portfolio and ranks #241 among its holdings. This is a return to the name: Hardy Reed previously reported a position in NVO as recently as Q4 2025.

Hardy Reed first reported a position in NVO in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.19M in Q2 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Hardy Reed held 4,546 shares of Novo Nordisk worth $218K as of Q2 2026.
Novo Nordisk was a new Hardy Reed position in Q2 2026.
Novo Nordisk made up 0.01% of Hardy Reed's portfolio in Q2 2026, its #241 holding.
Hardy Reed first reported a position in Novo Nordisk in Q2 2024 and has held it in 8 quarters since.
Hardy Reed's Novo Nordisk position peaked at $1.19M in Q2 2024.
1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hardy Reed's 13F filing for Q2 2026, filed 3 Aug 2026.